News
Stay informed about the latest developments and achievements from TRICALS.
Subscribe to our newsletterAll news
news
February 27, 2024
Tofersen receives positive opinion from CHMP (EMA)
Read more
news
January 10, 2024
Results ADORE study: no effect of medication
Read more
news
December 22, 2023
34th International Symposium on ALS/MND
Read more
news
December 14, 2023
3FM Serious Request takes action for ALS Foundation Netherlands
Read more
news
December 5, 2023
Over 200 patients participate in Lighthouse II study worldwide
Read more
news
September 20, 2023
ENCALS consensus statement on NurOwn
Read more
news
May 31, 2023
Story behind the participant: Peter Ambühl
Read more
news
May 23, 2023
Apellis reports discontinuation of MERIDIAN study
Read more
news
April 11, 2023
Recording of virtual meeting: Adherence and retention in ALS clinical trials
Read more
news
April 4, 2023
COURAGE-ALS trial discontinued due to disappointing results
Read more
news
March 7, 2023
TRICALS consensus statement on Tofersen
Read more
news
February 24, 2023
The ATLAS study - A clinical trial for people who want to contribute to SOD1-ALS research
Read more
news
October 6, 2022
Food and Drug Administration (FDA) approves AMX0035 (Amylyx) for the American market
Read more